Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Lamprene

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1997
Highly Cited
1997
Clofazimine (Lamprene) is an antimycobacterial drug that has antiinflammatory activity in a number of chronic autoimmune skin… Expand
  • table 2
  • table 1
  • table 3
1988
1988
The purpose of this study was to evaluate the effects of a delayed-type cell-mediated immune response to Mycobacterium… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
1983
1983
A 46-year-old woman with widespread prurigo nodularis was treated with 300 mg clofazimine a day for six months. Ten months after… Expand
Review
1981
Review
1981
Several categories of chemical and pharmacologic agents can cause alterations in cutaneous pigmentation, although the mechanisms… Expand
1981
1981
We have identified two metabolites of clofazimine (B663; Lamprene; 3-(p-chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2… Expand
1980
1980
A male patient aged 68 years, suffering from pyoderma gangrenosum which was resistant to conventional treatment, received… Expand
Review
1979
Review
1979
 
1978
1978
Lamprene (Clofazimine) was administered over a period of three months, at a dose of 100 mg to 200 mg per day, to six patients… Expand
Highly Cited
1976
Highly Cited
1976
Eight patients had pyoderma gangrenosum. They were given a phendimetrazine tartrate derivative, clofazimine (Lamprene [Britain… Expand
1976
1976
Clofazimine was administered, over a period of six months, in a dose of 100 mgm per day, to nine patients with discoid lupus… Expand